Phase 3 Mouth Disease Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis.
HalitosisPeridontal DiseaseBleeding Gum+2 more
Al-Mustansiriyah University54 enrolled1 locationNCT06882564
Recruiting
Phase 3
Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell)
Hand, Foot, and Mouth Disease（HFMD)
Sinovac Biotech Co., Ltd8,000 enrolled4 locationsNCT06734832
Completed
Phase 3
A double blind, randomised placebo controlled trial of topical 2% viscous lignocaine in improving oral intake in children with painful infectious mouth conditions.
gingivostomatitishand, foot and mouth diseaseulcerative pharyngitis+1 more
Sandy (Alexander) M Hopper100 enrolled1 locationACTRN12609000566235